Research
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence | Oncogenesis
Business-Academic Team to Create RNA Delivery for Cancer | Science and Enterprise
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
12th World Congress on Pharma Sciences & Innovations in Pharma Industry - طبيبي
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Mitarbeiter des Rudolf-Boehm-Institutes
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Achim Aigner: H-index & Awards - Academic Profile | Research.com
Nanomaterials | Free Full-Text | Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown
Pharmaceutics & Novel Drug Delivery Systems
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Pharmaceuticals | Free Full-Text | Role of Chemosensory TRP Channels in Lung Cancer
Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction
Role of Chemosensory TRP Channels in Lung Cancer
MedChemComm
Pharmaceutics Conferences | Drug Delivery Conferences | Pharmaceutica 2017 | Pharmaceutica 2018 | UK | Europe | Middle East | Asia Pacific | USA | Conference Series LLC LTD
Analysis of polymeric nanoparticle properties for siRNA/DNA delivery in a tumor xenograft tissue slice air–liquid interface model - Karimov - 2023 - Biotechnology Journal - Wiley Online Library
Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
Mitarbeiter des Rudolf-Boehm-Institutes
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
